FDA Approves ReSure Sealant from Ocular Therapeutix
Ocular Therapeutix announced today it has received approval from the Food and Drug Administration (FDA) to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery. The ReSure Sealant is the first and only sealant that is FDA-approved for ophthalmic use.
Posted on Thu, January 9, 2014
by Sarah Hokuf